Alkermes plc
ALKS
Rang in aandelen
#2726
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Aandeelprijs
$41.39
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$6.94B
Verandering (1 dag)
3.22%
Verandering (1 jaar)
36.78%
Land
IE
Handel Alkermes plc (ALKS)
Categorie
Healthcare
Operationele marge voor Alkermes plc (ALKS)
Operationele marge op October 2026 TTM: 7.03%
Volgens de meest recente financiële rapporten en aandelenkoers van Alkermes plc is de huidige operationele marge (TTM) 7.03%. Eind 2023 had het bedrijf een operationele marge van 24.90%.
Geschiedenis van de operationele marge van Alkermes plc van 2000 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 7.03% | -73.96% |
| 2024 | 27.00% | 8.43% |
| 2023 | 24.90% | -4,627.27% |
| 2022 | -0.55% | -106.60% |
| 2021 | 8.33% | -176.99% |
| 2020 | -10.82% | -27.82% |
| 2019 | -14.99% | 65.45% |
| 2018 | -9.06% | -44.65% |
| 2017 | -16.37% | -41.49% |
| 2016 | -27.98% | -21.62% |
| 2015 | -35.70% | 153.55% |
| 2014 | -14.08% | -199.09% |
| 2013 | 14.21% | 0.00% |
| 2012 | 14.21% | -162.77% |
| 2011 | -22.64% | -7.40% |
| 2010 | -24.45% | 1.28% |
| 2009 | -24.14% | -158.46% |
| 2008 | 41.29% | -3,659.48% |
| 2007 | -1.16% | -125.22% |
| 2006 | 4.60% | -43.90% |
| 2005 | 8.20% | -108.51% |
| 2004 | -96.39% | -61.15% |
| 2003 | -248.12% | 42.63% |
| 2002 | -173.96% | 50.88% |
| 2001 | -115.30% | 116.00% |
| 2000 | -53.38% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 38.59% | -94.51% |
US
|
|
| -149.01% | -121.20% |
US
|
|
| 25.57% | -96.36% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -95.90% |
NL
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.